(1→3)-Β-D-Glucan
Measures Beta D glucan levels in the serum to help detect fungal infections in the bloodstream, like Candida or Aspergillus. It is commonly used for diagnosing invasive fungal diseases.
(1→3)-Β-D-Glucan Test in Bengaluru Overview
The (1→3)-β-D-Glucan Test, also known as the Beta-D-Glucan (BDG) test, is a blood test used primarily to detect invasive fungal infections. It's a non-culture-based diagnostic tool that helps in the early detection of systemic fungal diseases, especially in immunocompromised patients.
Purpose of the Test
This test is used to detect the presence of fungal cell wall components (β-D-glucan) in the blood. It’s helpful for diagnosing:
- Invasive candidiasis (Candida species)
- Aspergillosis (Aspergillus species)
- Pneumocystis jirovecii pneumonia (PJP)
- Fusarium, Trichosporon, and other rare fungi
Who Should Get This Test?
- Immunocompromised patients:
- Cancer patients on chemotherapy
- Organ transplant recipients
- People with HIV/AIDS
- ICU patients with prolonged illness
- Patients with suspected invasive fungal infections but negative cultures
- When fungal infection is suspected in lungs, blood, or deep tissues
Who Should Get This Test?
- Immunocompromised patients:
- Cancer patients on chemotherapy
- Organ transplant recipients
- People with HIV/AIDS
- ICU patients with prolonged illness
- Patients with suspected invasive fungal infections but negative cultures
- When fungal infection is suspected in lungs, blood, or deep tissues
What is Beta-D-Glucan?
- (1→3)-β-D-glucan is a polysaccharide found in the cell walls of many fungi.
- It is released into the bloodstream during an active fungal infection.
- This test does not detect fungal DNA or the organism itself — it detects this fungal cell wall component.
Advantages of BDG Test
- Early diagnosis — can detect infection before symptoms or imaging
- Non-invasive
- Helps guide antifungal therapy decisions
- Useful for monitoring response to treatment
Clinical Use of BDG Test
Early Detection of Invasive Fungal Infections (IFIs)
- Detects fungal infections before cultures or imaging are positive
- Used in patients at high risk (immunocompromised, ICU, post-transplant, etc.)
- Helps guide early antifungal therapy, which can be life-saving.
No special preparations needed
- (1-3)-beta-d-glucan
- Result
Test code
5569
Specimen vol. and vacutainer information
| Specimen | Vacutainer | Volume |
|---|---|---|
| Serum | Yellow Vacutainer | 2 ML |
Specimen stability information
Serum
Specimen rejection criteria
Test run frequency
Every Day TIME - 11:00
Turn around time
Next Day
Performing locations
Department
- Eia - Infectious Section
CPT and Loinc codes
Package price
₹7500
Need Help?
Talk to our health experts for guidance on tests, reports, or bookings.
WhatsApp to Book Test(1→3)-Β-D-Glucan
₹7500